ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

House Panel Seeks Information From Drug Cos. On Health Law Agreements With White House -Bloomberg

DOW JONES NEWSWIRES Republicans on the House Energy and Commerce Committee are seeking information from several large drug companies about their agreements with the Obama administration during the formation of the health-care reform law, Bloomberg News reported Friday, citing three people familiar with the talks. One of the people said the Republicans turned to direct negotiations with the companies after trade group Pharmaceutical Research and Manufacturers of America didn't cooperate, Bloomberg reported. The committee is seeking documents and other information from Pfizer Inc. (PFE), Merck & Co. (MRK), Amgen Inc. (AMGN), Abbott Laboratories (ABT) and AstraZeneca PLC (AZN), Bloomberg reported. Rep. Michael Burgess (R., Texas) told Bloomberg that "this has been like pulling teeth, trying to get information." A spokesman for PhRMA said "we have been cooperating with the committee on an ongoing basis since the investigation began," Bloomberg reported. Full story at http://www.bloomberg.com/news/2012-05-04/obama-deal-with-drugmakers-said-to-be-probed-by-house.html -Dow Jones Newswires; 212-416-2900

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
03/19/201714:00:00Analyses Of PCSK9 Inhibitor Prescription Rejection Rates Demonstrate...
03/18/201708:00:00Lowering LDL Levels With Repatha® (Evolocumab) Did Not Adversely...
03/17/201719:48:00Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke...
03/17/201714:05:00Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke...
03/17/201714:00:00Amgen's Money-Back Guarantee
03/17/201712:14:00Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke...
03/17/201709:29:00Amgen's Repatha Study Shows Reduced Risk of Heart Attack, Stroke
03/17/201709:00:00Landmark Outcomes Study Shows That Repatha® (Evolocumab) Decreases...
03/16/201716:00:00Amgen To Present At The Oppenheimer Global Health Care Conference
03/15/201717:18:54Securities Registration: Employee Benefit Plan (s-8)
03/15/201717:11:01Securities Registration: Employee Benefit Plan (s-8)
03/15/201717:05:47Securities Registration: Employee Benefit Plan (s-8)
03/14/201716:15:00Repatha® (Evolocumab) Four-Year Open-Label Follow-Up Study Published...
03/14/201716:00:00Amgen To Webcast Investor Meeting At Upcoming American College...
03/13/201709:00:00Repatha® (Evolocumab) Demonstrates Reduced Need For Apheresis...
03/09/201717:26:32Statement of Changes in Beneficial Ownership (4)
03/09/201717:22:12Statement of Changes in Beneficial Ownership (4)
03/09/201717:19:10Statement of Changes in Beneficial Ownership (4)
03/09/201717:15:44Statement of Changes in Beneficial Ownership (4)
03/09/201717:12:39Statement of Changes in Beneficial Ownership (4)

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US